Manmeet Singh Soni has bought stock on 3 days since Aug 2020

Soni Manmeet Singh is a corporate insider and senior biopharmaceutical executive who has served as COO, CFO, and President of Reata Pharmaceuticals Inc. (RETA), where he reported multiple insider transactions in the company’s stock, including option exercises and share sales documented in SEC Form 4 filings.( At Reata, he held combined operational and financial leadership responsibilities as Executive Vice President, Chief Operating Officer, Chief Financial Officer, and later President, overseeing the company’s business operations and financial strategy while building a significant personal shareholding in RETA.(

Singh is a person, not a company, and is a long‑tenured industry CFO/COO whose career spans several publicly listed biopharmaceutical firms.( Beyond Reata, he has served as Chief Operating Officer and Chief Financial Officer of Summit Therapeutics Inc. (SMMT), where he continues to be an officer and director and remains an active insider through substantial equity purchases and holdings.( His prior and concurrent roles include board and executive positions at companies such as Pulse Biosciences, Alnylam Pharmaceuticals, Arena Pharmaceuticals, Ariad Pharmaceuticals, and Pharmacyclics, reflecting a track record in growth-stage and commercial-stage life sciences organizations.( Public filings and market profiles identify him as a CPA, underscoring formal accounting credentials that support his repeated selection for top finance and operations roles in the sector.(

Written by Perplexity from public sources.